Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
Individualized Management in Primary Care
Scientific and Clinical Insights Into Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
Baseline Factors as Predictors of Clinical Progression of Benign Prostatic Hyperplasia in Men Treated With Placebo
Crawford ED, et al. J Urol. 2006;175:1422-1426.
The Correlation Between Metabolic Syndrome and Prostatic Diseases
De Nunzio C, et al. Eur Urol. 2012;61:560-570.
A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
Gacci M, et al. Eur Urol. 2012;61:994-1003.
The Mechanism of Action of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia
Giuliano F, et al. Eur Urol. 2013;63:506-516.
Medical Management of Lower Urinary Tract Symptoms
Laborde EE, McVary KT. Rev Urol. 2009;11(suppl 1):S19-S25.
Efficacy of α-Adrenergic Receptor Blockers in the Treatment of Male Lower Urinary Tract Symptoms
Roehrborn CG. Rev Urol. 2009;11(suppl 1):S1-S8.
The Effect of Benign Lower Urinary Tract Symptoms on Subsequent Prostate Cancer Testing and Diagnosis
Weight CJ, et al. Eur Urol. 2013;63:1021-1027.
A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting
Rosenberg MT, et al. Int J Clin Pract. 2007;61:1535-1546.
Tools
American Urological Association Symptom Index Questionnaire
The American Urological Association Symptom Index is used to evaluate the severity of symptoms associated with lower urinary tract symptoms. Urinary symptom scores of 1-7 suggest mild symptoms, 9-19 indicate moderate symptoms, and 20-35 denote severe symptoms.
Barry M, et al. J Urol. 1992;148:1549-1557.
Guidelines
Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia
Guideline statements graded as a standard of care, a recommendation, or an option address studies published before February 2008.
McVary KT, et al. J Urol. 2011;185:1793-1803.
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 version of the European Association of Urology guidelines on the treatment and follow-up of male lower urinary tract symptoms.
Oelke M, et al. Eur Urol. 2013 Mar 13. [Epub ahead of print]
Male Hypogonadism
Best Practices in Diagnosis and Management
| Faculty: | Steven A. Kaplan, MD |
| Release: | 02/12/2014 |
| Expiration: | 02/11/2015 |
